Literature DB >> 22304533

Important areas of the central binocular visual field for daily functioning in the visually impaired.

Daryl R Tabrett1, Keziah Latham.   

Abstract

PURPOSE: To determine the areas of the central binocular visual field which correspond best with self-reported vision related activity limitations (VRAL) in individuals with visual impairment using a clinically relevant and accessible technique.
METHODS: One hundred participants with mixed visual impairment undertook binocular threshold visual field testing using a Humphrey 30-2 SITA Fast program. The Activity Inventory (AI) was administered to assess overall, mobility related and reading related self-reported VRAL as part of a face-to-face clinical interview. Different eccentricities of the binocular field (central 5, 5-10, and 10-30°) were compared to self-reported VRAL in bivariate analyses and further explored using multivariate analyses.
RESULTS: All areas of the binocular visual field were significantly associated with self-reported VRAL in bivariate analyses, with greater field loss associated with increased VRAL (p < 0.001). Multivariate analyses identified that function of the central 5-10° best predicted overall self-reported VRAL, and function of the central 5° (especially the right-hand-side) and the central 10-30° (especially 10-20°) best predicted self-reported VRAL in reading and mobility tasks, respectively.
CONCLUSIONS: The results highlight the association between central binocular visual fields and self-reported VRAL in people with visual impairment. Central binocular fields can be measured using a widely available threshold test in order to understand the likely functional limitations of those with vision loss, particularly in mobility tasks. Self-reported VRAL can be estimated using the regression equations and graphs provided and difficulty levels in specific tasks can be determined. Ophthalmic & Physiological Optics
© 2012 The College of Optometrists.

Entities:  

Mesh:

Year:  2012        PMID: 22304533     DOI: 10.1111/j.1475-1313.2012.00892.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  8 in total

1.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

2.  Areas of the visual field important during reading in patients with glaucoma.

Authors:  Robyn Burton; Luke J Saunders; David P Crabb
Journal:  Jpn J Ophthalmol       Date:  2014-12-26       Impact factor: 2.447

3.  Functional visual fields: a cross-sectional UK study to determine which visual field paradigms best reflect difficulty with mobility function.

Authors:  Hikmat Subhi; Keziah Latham; Joy Myint; Michael Crossland
Journal:  BMJ Open       Date:  2017-11-20       Impact factor: 2.692

4.  A New Graphical Tool for Assessing Visual Field Progression in Clinical Populations.

Authors:  Susan R Bryan; David P Crabb
Journal:  Transl Vis Sci Technol       Date:  2018-02-28       Impact factor: 3.283

Review 5.  Topical Review: Assessment of Binocular Sensory Processes in Low Vision.

Authors:  Janelle Tong; Jessie Huang; Vincent Khou; Jodi Martin; Michael Kalloniatis; Angelica Ly
Journal:  Optom Vis Sci       Date:  2021-04-01       Impact factor: 2.106

6.  Longitudinal Impact of Vision Impairment on Concern About Falling in People With Age-Related Macular Degeneration.

Authors:  Ursula E White; Alex A Black; Kim Delbaere; Joanne M Wood
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

7.  Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up.

Authors:  Dorothea Peters; Anders Heijl; Lena Brenner; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2015-09-18       Impact factor: 3.761

8.  Assessing Functional Disability in Glaucoma: The Relative Importance of Central Versus Far Peripheral Visual Fields.

Authors:  Jamie L Odden; Aleksandra Mihailovic; Michael V Boland; David S Friedman; Sheila K West; Pradeep Y Ramulu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.